Literature DB >> 1712684

T cell interactions in active rheumatoid arthritis: insights from the human autologous mixed lymphocyte reaction as a model of T cell activation cascade.

T Sakane1, Y Murakawa, M Takeno, T Shigeki, H Nagafuchi, T Miki.   

Abstract

The autologous mixed lymphocyte reaction (AMLR) represents the activation, proliferation and differentiation of T cells in response to signals from autologous non-T cells. Using monoclonal anti-Leu8 antibody to isolate subpopulations of human CD4+ and CD8+ T cells, we have investigated the role of these subpopulations in the T cell activation cascade during the course of AMLR. In normal subjects, CD4+Leu8+ cells are necessary for the initiation of the AMLR response, and sequentially lead to activation and proliferation of both CD4+Leu8- cells and CD8+Leu8+ cells. The activated CD8+Leu8+ cells, in turn, induce CD8+Leu8- cells to generate proliferation of the latter cells. Soluble mediators could be involved in the T cell activation cascade induced by the AMLR. Patients with active rheumatoid arthritis have a profound defect in the AMLR. Further analysis indicates that rheumatoid arthritis CD8+ T cells are markedly defective as responding cells in the AMLR. The impaired AMLR response by CD8+ cells cannot be reconstituted with AMLR-derived supernatants from normal T cells. The data suggest that the defective CD8+ T cell function may contribute to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712684      PMCID: PMC1535717          DOI: 10.1111/j.1365-2249.1991.tb05681.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

Review 1.  T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease.

Authors:  C S Via; G M Shearer
Journal:  Immunol Today       Date:  1988 Jul-Aug

2.  Impaired autologous mixed lymphocyte reaction (AMLR) reactivity of peripheral blood T cell subsets in rheumatoid arthritis.

Authors:  E C Keystone; L Poplonski; K M Snow; M Martell
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.

Authors:  C Morimoto; P L Romain; D A Fox; P Anderson; M DiMaggio; H Levine; S F Schlossman
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

4.  Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.

Authors:  T Takeuchi; C E Rudd; S F Schlossman; C Morimoto
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

5.  Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor.

Authors:  D Camerini; S P James; I Stamenkovic; B Seed
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

6.  Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.

Authors:  G S Kansas; G S Wood; D M Fishwild; E G Engleman
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

7.  Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritis.

Authors:  S M Cross; R A Hazelton
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

8.  Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2.

Authors:  S Takada; Y Ueda; N Suzuki; Y Murakawa; T Hoshino; I Green; A D Steinberg; D A Horwitz; T Sakane
Journal:  Eur J Immunol       Date:  1985-03       Impact factor: 5.532

9.  Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis.

Authors:  P Emery; K C Gentry; I R Mackay; K D Muirden; M Rowley
Journal:  Arthritis Rheum       Date:  1987-08

10.  Phenotypic identification of suppressor-effector, suppressor-amplifier and suppressor-inducer T cells of B cell differentiation in man.

Authors:  G S Kansas; E G Engleman
Journal:  Eur J Immunol       Date:  1987-04       Impact factor: 5.532

View more
  3 in total

Review 1.  Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

Authors:  L Georgescu; S A Paget
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

2.  Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease.

Authors:  N Yoshikawa; T Morita; E Resetkova; G Arreanza; P Carayon; R Volpé
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

Review 3.  Circadian Clock and Complement Immune System-Complementary Control of Physiology and Pathology?

Authors:  Pooja Shivshankar; Baharan Fekry; Kristin Eckel-Mahan; Rick A Wetsel
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.